Bruker Corporation (NASDAQ:BRKR) Given Consensus Rating of “Hold” by Analysts

Bruker Corporation (NASDAQ:BRKR) has been assigned a consensus recommendation of “Hold” from the eleven brokerages that are covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, five have issued a hold recommendation and five have issued a buy recommendation on the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is $51.00.

Several equities research analysts have issued reports on BRKR shares. Barclays dropped their price target on Bruker from $43.00 to $40.00 and set an “overweight” rating for the company in a research note on Thursday, October 2nd. Wells Fargo & Company dropped their price target on Bruker from $60.00 to $50.00 and set an “overweight” rating for the company in a research note on Tuesday, August 5th. Stifel Nicolaus set a $40.00 price target on Bruker and gave the stock a “hold” rating in a research note on Tuesday, August 5th. Jefferies Financial Group set a $60.00 price target on Bruker and gave the stock a “buy” rating in a research note on Monday, August 4th. Finally, Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Bruker in a research note on Wednesday, October 8th.

Insider Transactions at Bruker

In other news, Director Cynthia M. Friend sold 3,535 shares of the business’s stock in a transaction dated Friday, September 12th. The stock was sold at an average price of $32.25, for a total value of $114,003.75. Following the completion of the sale, the director owned 18,016 shares of the company’s stock, valued at approximately $581,016. The trade was a 16.40% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 27.30% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Bruker

A number of hedge funds and other institutional investors have recently modified their holdings of BRKR. Wealth Enhancement Advisory Services LLC lifted its stake in shares of Bruker by 81.2% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 29,826 shares of the medical research company’s stock valued at $1,245,000 after acquiring an additional 13,367 shares during the last quarter. Pinnacle Bancorp Inc. bought a new stake in shares of Bruker in the 1st quarter valued at about $29,000. Diversified Trust Co bought a new stake in shares of Bruker in the 1st quarter valued at about $378,000. Allspring Global Investments Holdings LLC lifted its stake in shares of Bruker by 1.1% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 216,866 shares of the medical research company’s stock valued at $8,757,000 after acquiring an additional 2,286 shares during the last quarter. Finally, KBC Group NV lifted its stake in shares of Bruker by 0.8% in the 1st quarter. KBC Group NV now owns 44,715 shares of the medical research company’s stock valued at $1,866,000 after acquiring an additional 349 shares during the last quarter. Institutional investors own 79.52% of the company’s stock.

Bruker Price Performance

NASDAQ:BRKR opened at $38.72 on Friday. The firm has a market capitalization of $5.87 billion, a price-to-earnings ratio of 74.46, a P/E/G ratio of 5.44 and a beta of 1.20. Bruker has a 52-week low of $28.53 and a 52-week high of $64.64. The stock has a fifty day moving average of $34.24 and a 200 day moving average of $37.00. The company has a debt-to-equity ratio of 1.31, a quick ratio of 0.70 and a current ratio of 1.61.

Bruker (NASDAQ:BRKR) last posted its quarterly earnings data on Monday, August 4th. The medical research company reported $0.32 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.33 by ($0.01). The business had revenue of $797.40 million for the quarter, compared to the consensus estimate of $811.17 million. Bruker had a net margin of 2.31% and a return on equity of 17.89%. Bruker’s quarterly revenue was down .4% on a year-over-year basis. During the same period in the prior year, the business posted $0.52 EPS. Bruker has set its FY 2025 guidance at 1.950-2.050 EPS. On average, research analysts expect that Bruker will post 2.69 EPS for the current fiscal year.

Bruker Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, October 3rd. Shareholders of record on Tuesday, September 23rd were paid a dividend of $0.05 per share. The ex-dividend date of this dividend was Tuesday, September 23rd. This represents a $0.20 annualized dividend and a yield of 0.5%. Bruker’s payout ratio is 38.46%.

Bruker Company Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.